|Bid||0.77 x 0|
|Ask||0.81 x 0|
|Day's Range||0.7700 - 0.8100|
|52 Week Range||0.6800 - 2.2800|
|Beta (3Y Monthly)||4.34|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 25, 2019 - Mar 1, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
/THE SECURITIES HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES ABSENT SUCH REGISTRATION OR AN APPLICABLE EXEMPTION FROM SUCH REGISTRATION REQUIREMENTS. WKN: A1C4WM) ("Aurora") as well as 1,330 Debentures to other Offering participants for gross proceeds to date of $11,330,000 .
WKN: A1C4WM) announced today that, further to the Company's press release dated December 7, 2018 , the Company has entered into a Letter of Intent to acquire all of the issued and outstanding shares of Farmacias Magistrales S.A. ("Farmacias"), subject to customary due diligence provisions, the completion of definitive agreements, and regulatory and government approval. As previously announced, Farmacias recently became Mexico's first and only federally licensed importer to date of raw materials containing THC, gaining the necessary licenses, facilities, and permissions to import raw THC material, and manufacture, store, and distribute medical cannabis products containing over 1% THC.
Aurora Cannabis to Enter Mexico Market via Exclusive Supply Arrangement with Farmacias Magistrales
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI) announced today that it has released its financial results for the second fiscal quarter ended September 30, 2018. In addition, the Company also closed a non-brokered private placement for an additional $9.4M. Subsequent to the second fiscal quarter, on October 29th, 2018, the Company was approved for graduation to “Tier 1 Issuer” status from its prior status as a “Tier 2 Issuer” by the TSX Venture Exchange (the “TSXV”).
WKN: A1C4WM) announced today that the company, through a selling broker, has completed the sale in the open market of the Australis Capital Inc. ("Australis") units on behalf of non-resident shareholders. Payment of the net cash proceeds from the sales of Australis units to the non-resident shareholders of record as of August 24, 2018 was completed by the custodian on November 27, 2018 . In total, 11,222,349 units of Australis were sold in the public markets.
WKN: A1C4WM) announced today that the company has received an export request, has secured the required export permit and has now completed its first shipment of medical cannabis products to the Czech Republic , making this the 21st country in which the company operates. The initial purchase order was placed by, and products will be shipped to Czech Medical Herbs s.r.o. Czech Medical Herbs is a distributor of medicinal products with a specialization in Cannabis for medical use and medicinal products based on cannabinoids.
The big shareholder groups in Radient Technologies Inc (CVE:RTI) have power over the company. Institutions often own shares in more established companies, while it’s not unusual to see insiders own Read More...
WKN: A1C4WM) and ICC Labs Inc. (ICC.V) ("ICC") are pleased to announce today the completion of the previously announced plan of arrangement (the "Arrangement") pursuant to which Aurora has acquired all of the issued and outstanding common shares of ICC for $1.95 per share (payable in common shares of Aurora (the "Aurora Shares")), reflecting an aggregate purchase price of approximately $290 million . ICC is now a wholly-owned subsidiary of Aurora.
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI) is pleased to announce that it has received its Confirmation of Readiness (“COR”) Letter from Health Canada in regard to its application for an initial Standard Processor’s License (the “License”) pursuant to the new Cannabis Act regulations. This COR Letter pertains to the Company’s recently expanded Manufacturing Facility located at 4035 101 St NW in Edmonton, Alberta.
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI) is pleased to announce that it has now filed an additional 13 provisional patent applications with the United States Patent and Trademark Office (the “USPTO”). Additionally, the Company is pleased to announce that it has entered into a Facilities Access and Technical Services Agreement (the “Agreement”) with Processium, a company based in the Lyon area of France.
This Order from Aurora is for a customized line of smoking accessories across multiple categories including bubblers, grinders, hand pipes, hemp wicks, sherlocks, vaporizers and water pipes. High Tide has commenced the process of converting its proprietary designs into manufactured products for its new client.
EDMONTON, Alberta, Nov. 08, 2018 -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI) today announces that all resolutions were passed by the requisite.
Radient Technologies Inc. (TSX Venture: RTI) and Grupo Natac S.L. (Natac) are pleased to announce the formal launch of their joint venture Natac Solutions at SupplySide West November 7-9, 2018 in Las Vegas, Nevada. Natac Solutions will bring revolutionary health and wellness ingredients to the market and will be showing at SupplySide West (Booth 5334) for its first industry appearance.
Advanced-Efficacy Extracts Offer Condition-Specific Functional Benefits EDMONTON, Alberta and MADRID, Spain, Nov. 07, 2018 -- Radient Technologies Inc. (TSX Venture: RTI) and.
At 48,000 square feet, with 11 purpose-built grow rooms, Aurora Eau will produce up to 4,500 kg of high quality cannabis per year, all in a facility with some of the lowest electricity costs in North America . It is designed to grow niche varieties of cannabis for the premium medical and adult consumer use markets in Quebec, Canada and around the world.
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI) is pleased to announce it has appointed Mr. Christian Aigner to the position of Managing Director, Germany. Reporting to Radient’s Chief Operating Officer, Mr. Aigner will be responsible for the development and management of Radient’s German processing facility, and will also provide valuable direction to the overall design and execution of each of Radient’s global manufacturing projects. Mr. Aigner brings to Radient more than 30 years’ experience in the design, construction, and optimization of pharmaceutical and manufacturing facilities, including 10 years as Operational Excellence Manager with Sandoz GmbH in Kundl, Austria.
OTCQB: CHOOF) ( "Choom") an emerging adult use cannabis company that has secured one of the largest retail networks in Canada , are pleased to announce that the companies have completed a non-brokered private placement of a debenture (the "Offering") in the principal amount of $20,000,000 in Choom by Aurora, convertible into common shares of Choom ("Common Shares") at a conversion price of $1.25 per Common Share, with a four year maturity date.
WKN: A1C4WM) and ICC Labs Inc. ( ICC ) (ICC.V) are pleased to announce that Aurora has received, from its consortium of lenders led by Bank of Montreal (collectively, the Lenders), consent and approval as required under its credit agreement with the Lenders to the previously announced plan of arrangement (the Arrangement) between ICC and Aurora. Subject to the terms and conditions of the arrangement agreement dated September 8, 2018 (the Arrangement Agreement), Aurora will acquire all of the issued and outstanding common shares (ICC Shares) of ICC.